Market Research Logo

Skin Disease Treatment Technologies and Global Markets

Skin Disease Treatment Technologies and Global Markets

The global market for skin disease treatment technologies reached $16.4 billion in 2014 and $17.1 billion in 2015. The market should reach $20.4 billion in 2020, demonstrating a compound annual growth rate (CAGR) of 3.6% from 2015 to 2020.

This report provides:
An overview of the global market for treatments of skin diseases, perhaps the most common of human afflications.
Analyses of global market trends, with data from 2014, 2015, and projections of compound annual growth rates (CAGRs) through 2020.
Focused coverage of four major categories of skin disease of exceptional medical and commercial significance: dermatitis (allergic and contact), cancers (including melanoma), immune disorders (including psoriasis), and infections (bacterial, fungal and viral).
Topics such as skin structure and function, diseases of the skin, current treatment options, and unmet clinical needs.
Discussion of the evolution of the market, including the rising prevalence of some skin diseases, and new diagnostic and treatment options.
Examination of the global market by product categories, such as anti-allergic products, antibacterials, antifungals, antivirals, immunotherapies, and anticancers.
Profiles of major players in the industry.


SCOPE OF REPORT

This report discusses the implications of the above-mentioned trends in the context of the current size and growth of the dermatology market, discussed both in global terms and in reference to the most important national markets. Long-standing and emerging companies are discussed, with profiles of their leadership and an update on M&A activity. Five-year global sales forecasts are provided for main drug categories, and breakdowns are provided for several national markets.

CHAPTER 1 INTRODUCTION
STUDY GOALS AND OBJECTIVES
REASONS FOR DOING THE STUDY
SCOPE OF REPORT
MARKET ANALYSES AND FORECASTS
METHODOLOGY
INTENDED AUDIENCE
INFORMATION SOURCES
ANALYST'S CREDENTIALS
RELATED BCC RESEARCH REPORTS
BCC RESEARCH WEBSITE
DISCLAIMER
CHAPTER 2 SUMMARY
SKIN DISEASE AND ITS TREATMENT
DISEASES INCLUDED
TREATMENTS
ABOUT THE MARKET
LEADING COMPANIES
SUMMARY TABLE GLOBAL MARKET FOR SKIN DISEASE TREATMENT TECHNOLOGIES BY REGION, THROUGH 2020 ($ MILLIONS)
SUMMARY FIGURE GLOBAL MARKET FOR SKIN DISEASE TREATMENT TECHNOLOGIES BY REGION, 2013-2020 ($ MILLIONS)
CHAPTER 3 OVERVIEW
SKIN STRUCTURE AND FUNCTIONS
STRUCTURE
Epidermis
Basement Membrane
Dermis
Hypodermis
FUNCTIONS
SKIN DISEASES
CHAPTER 4 MAJOR SKIN DISEASES
DERMATITIS
SEBORRHEIC DERMATITIS
Available Treatments
ATOPIC DERMATITIS, ECZEMA
Available Treatments
CONTACT DERMATITIS
Irritant Contact Dermatitis
Available Treatments
Allergic Contact Dermatitis
Available Treatments
DERMATITIS PIPELINE
TABLE 1 PRODUCTS UNDERGOING RESEARCH AS POTENTIAL
TREATMENTS FOR DERMATITIS
TABLE 2 GLOBAL MARKET FOR DERMATITIS BY TYPE, THROUGH 2020 ($ MILLIONS)
IMMUNE-RELATED CONDITIONS
LUPUS ERYTHEMATOSUS
Treatments Available
Pipeline
TABLE 3 COMPOUNDS UNDER DEVELOPMENT FOR CUTANEOUS LUPUS TREATMENT
IMMUNOBULLOUS DISEASES
Treatments Available
Market
TABLE 4 GLOBAL MARKET FOR IMMUNE-RELATED SKIN DISEASES BY TYPE, THROUGH 2020 ($ MILLIONS)
LICHEN PLANUS
Treatments Available
ERYTHEMA MULTIFORME
Treatments Available
PSORIASIS
SUBTYPES
Plaque Psoriasis
Guttate Psoriasis
Erythrodermic Psoriasis
Pustular Psoriasis
Psoriasis of the Nails
TREATMENTS AVAILABLE
Topical Therapies Available
Emollients
Keratolytics
Topical Corticosteroids
Vitamin D3 Products
Tazarotene
Tar Preparations
Anthralin
Topical Immunomodulators
Intralesional Therapy
Phototherapy with UVB
Photochemotherapy (PUVA)
Systemic Therapy
Methotrexate
Acitretin
Cyclosporine
Hydroxyurea
Cytokine Antagonists and Other Immunomodulators
PSORIASIS TREATMENT BENEFITS AND RISKS
MAJOR ENGINEERED PROTEIN TREATMENTS IN USE
Etanercept (Enbrel)
Adalimumab (Humira)
Infliximab (REMICADE)
Ustekinumab (STELARA)
Alefacept (Amevive)
Cost of Treatment
TABLE 5 COST OF PSORIASIS THERAPIES IN A TYPICAL WESTERN EUROPEAN COUNTRY ($)
PSORIASIS TREATMENT PIPELINE
PSORIASIS TREATMENT MARKET
TABLE 6 GLOBAL MARKET FOR PSORIASIS BY REGION, THROUGH 2020 ($ MILLIONS)
SKIN INFECTIONS
BACTERIAL INFECTIONS
Impetigo/Ecthyma
Cellulitis
Treatments Available
Necrotizing Subcutaneous Infection
Treatments Available
FUNGAL INFECTIONS
Candidiasis
Treatments Available
TABLE 7 ANTIFUNGALS FOR SUPERFICIAL FUNGAL INFECTIONS
Tinea Versicolor
Treatments Available
VIRAL INFECTIONS
Herpes Simplex
Treatments Available
Herpes Zoster
Treatments Available
Warts
Treatments Available
TABLE 8 ANTIVIRAL DRUGS AVAILABLE
SKIN INFECTION TREATMENT PIPELINE
TABLE 9 POTENTIAL DRUG CANDIDATES FOR SKIN INFECTION
TREATMENTS
ANTI-INFECTIVE MARKET
TABLE 10 GLOBAL MARKET FOR SKIN INFECTIONS BY TYPE, THROUGH 2020 ($ MILLIONS)
ACNE
Comedonal
Papulopustular
Nodulocystic
Treatments Available
Retinoids
Antibiotics
Anti-inflammatory Drugs
Hormonal Therapy
Treatment Failure
ACNE TREATMENT PIPELINE
TABLE 11 POTENTIAL PRODUCTS FOR ACNE TREATMENT
ACNE TREATMENT MARKET
TABLE 12 GLOBAL MARKET FOR ACNE MEDICATIONS BY TYPE, THROUGH 2020 ($ MILLIONS)
SKIN CANCERS
MELANOMA
Treatments Available
NONMELANOMA SKIN CANCERS
Basal Cell Carcinoma
Squamous Cell Carcinoma
SKIN CANCER TREATMENT PIPELINE
TABLE 13 PRODUCTS IN PIPELINE FOR SKIN CANCER THERAPEUTICS SKIN CANCER TREATMENT MARKET
TABLE 14 GLOBAL MARKET FOR SKIN CANCER THERAPEUTICS, THROUGH 2020 ($ MILLIONS)
CHAPTER 5 DERMATOLOGY PRODUCTS
DESCRIPTIONS
CHAPTER 6 CURRENT AND FORECAST MARKETS
DEVELOPED MARKETS
U.S.
TABLE 15 U.S. ANNUAL DIRECT COST OF PRESCRIPTION DRUGS, 2004 ($ MILLIONS)
TABLE 16 U.S. MARKET FOR PRESCRIPTION DERMATOLOGY DRUGS, THROUGH 2020 ($ MILLIONS/%)
JAPAN
TABLE 17 JAPANESE MARKET FOR PRESCRIPTION DERMATOLOGY DRUGS, THROUGH 2020 ($ MILLIONS/%)
GERMANY
TABLE 18 GERMAN MARKET FOR PRESCRIPTION DERMATOLOGY DRUGS, THROUGH 2020 ($ MILLIONS/%)
FRANCE
TABLE 19 FRENCH MARKET FOR PRESCRIPTION DERMATOLOGY DRUGS, THROUGH 2020 ($ MILLIONS/%)
ITALY
TABLE 20 ITALIAN MARKET FOR PRESCRIPTION DERMATOLOGY DRUGS, THROUGH 2020 ($ MILLIONS/%)
SPAIN
TABLE 21 SPAIN'S MARKET FOR PRESCRIPTION DERMATOLOGY DRUGS, THROUGH 2020 ($ MILLIONS/%)
UNITED KINGDOM
TABLE 22 U.K. MARKET FOR PRESCRIPTION DERMATOLOGY DRUGS, THROUGH 2020 ($ MILLIONS/%)
BRIC MARKETS
BRAZIL
TABLE 23 BRAZILIAN MARKET FOR PRESCRIPTION DERMATOLOGY DRUGS, THROUGH 2020 ($ MILLIONS/%)
RUSSIA
TABLE 24 RUSSIAN MARKET FOR PRESCRIPTION DERMATOLOGY DRUGS, THROUGH 2020 ($ MILLIONS/%)
INDIA
TABLE 25 INDIA'S MARKET FOR PRESCRIPTION DERMATOLOGY DRUGS, THROUGH 2020 ($ MILLIONS/%)
CHINA
TABLE 26 HEALTHCARE STATISTICS IN CHINA, 2006 VERSUS 2011 ($ BILLIONS/%)
TABLE 27 CHINESE MARKET FOR PRESCRIPTION DERMATOLOGY DRUGS, THROUGH 2020 ($ MILLIONS/%)
CHAPTER 7 THE DERMATOLOGY INDUSTRY
INDUSTRY STRUCTURE AND TRENDS
COMPANY PROFILES
ABBVIE
AGENUS
AICURIS GMBH & CO. KG
ALLERGAN
ALMIRALL
AMGEN
ANACOR PHARMACEUTICALS INC.
ANGES MG
APEIRON BIOLOGICS AG
ASTELLAS PHARMA INC.
ASTION PHARMA A/S
ASTRAZENECA
BARRIER THERAPEUTICS
BASILEA PHARMACEUTICA LTD.
BRISTOL-MYERS SQUIBB
CELGENE
CIPHER PHARMACEUTICALS
DUSA PHARMACEUTICALS INC.
ELI LILLY
GALDERMA PHARMA SA/GALDERMA SA
GENENTECH
GLAXOSMITHKLINE
HANALL BIOPHARMA
IMMUNE TECHNOLOGIES & MEDICINE
INCYTE
JANSSEN BIOTECH
KAKEN PHARMACEUTICALS
LEO PHARMA A/S
MEDA AB
NANOBIO
NAVIDEA BIOPHARMACEUTICALS
NITRIC BIOTHERAPEUTICS
NOVARTIS INTERNATIONAL
PFIZER
PHOTOCURE
REGENERON PHARMACEUTICALS INC.
STIEFEL, A GSK COMPANY
SWITCH BIOTECH
VALEANT PHARMACEUTICALS INTERNATIONAL INC.
CHAPTER 8 APPENDIX I: GLOSSARY
CHAPTER 9 APPENDIX II: THE IMMUNE SYSTEM
TWO DEFENSE STRATEGIES
HUMORAL IMMUNITY
CELLULAR IMMUNITY
MARKERS OF SELF
HUMORAL IMMUNITY: B LYMPHOCYTES
CELLULAR IMMUNITY: T LYMPHOCYTES
REGULATORY T CELLS
CYTOTOXIC T CELLS
NATURAL IMMUNITY
TABLE 28 IMMUNOTHERAPEUTICS IN SKIN DISEASES

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report